NEW YORK – Congenica said Monday that it has entered into a distribution agreement with Amplitech to distribute its products in France and other French-speaking European countries.
AmpliTech, based in Compiègne, France, will distribute Congenica's clinical decision support platform, allowing the Cambridge, UK-based firm to enter the French market for the first time.
AmpliTech distributes software and instruments for in vitro diagnostics and research to hospitals and laboratories in France, Belgium, Switzerland, and Luxembourg.
Anna Tucker, director of EMEA distributor sales for Congenica, reiterated in a statement that the company is actively looking to expand into new markets as well as new medical indications. "By signing this distribution agreement, we are able to support the rapidly growing genomics market in France," Tucker added.
"We believe that Congenica's software has the potential to transform the genomic analysis capabilities of research institutions, diagnostic laboratories, and hospitals throughout France," said AmpliTech General Manager Gilles Cestelli. "With the French genomics market growing rapidly, we envisage a future where genomic medicine can be incorporated into standard clinical practice, enabled by Congenica."